The FDA is expected to decide on treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity.

ARPA-H PROSPR program to support the development of TPN-101 to slow aging and help people stay healthy longerSAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Transposon Therapeutics, a biotechnology ...

Children and adolescents in low- and middle-income countries living with HIV showed a reduced viral load after treatment with ...

A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia. A new study published in Science Advances has identified higher levels of two biological markers in ...

A recent study confirms lenacapavir's effectiveness against HIV and highlights the capsid as a promising drug target despite resistance.

Called “Lamarckian Inheritance,” the theory suggests that those experiences can even be passed down to future generations.

Children with HIV on dolutegravir (Tivicay)-based antiretroviral therapy (ART) can safely receive the standard prophylactic ...

Radiation therapy is highly effective at killing cancer cells, but it often harms healthy skin around the treatment area, a common side effect experienced by up to 95% of cancer patients undergoing ...

Researchers uncover how manual acupuncture targets spinal inflammation to relieve rheumatoid arthritis pain. Read more!

Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether ...

A NEW point-of-care fingerstick test detects hepatitis B virus (HBV) within one hour, a 2026 diagnostic study has found. The accuracy and reliability of the Xpert HBV Viral Load test, using ...

IMPAACT 2017 (MOCHA) week 96 results show long-acting Cabenuva (cabotegravir + rilpivirine) effectively maintained viral suppression in 94.4% of adolescents aged 12 to <18 years Additional paediatric ...